New Leaf Venture Partners logo

New Leaf Venture Partners

North America, New York, United States, New York

Description

New Leaf Venture Partners is a venture capital firm focused on investments in healthcare technology companies.

Investor Profile

New Leaf Venture Partners has made 168 investments, with 2 in the past 12 months and 24% as lead.

Stage Focus

  • Series B (25%)
  • Series Unknown (18%)
  • Series C (17%)
  • Series A (13%)
  • Post Ipo Equity (7%)
  • Series D (7%)
  • Series E (4%)
  • Series F (3%)
  • Debt Financing (2%)
  • Private Equity (2%)

Country Focus

  • United States (92%)
  • United Kingdom (4%)
  • Canada (1%)
  • Ireland (1%)
  • Switzerland (1%)
  • Denmark (1%)
  • Israel (1%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Therapeutics
  • Pharmaceutical
  • Health Diagnostics
  • Biopharma
  • Information Technology
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does New Leaf Venture Partners frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 26
SV Health Investors
North America, Massachusetts, United States, Boston
Co-Investments: 11
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 17
Three Arch Partners
North America, California, United States, Portola Valley
Co-Investments: 14
Bay City Capital
North America, California, United States, San Francisco
Co-Investments: 9
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 15
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 11
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 13
Frazier Healthcare Partners
North America, Washington, United States, Seattle
Co-Investments: 10
Venrock
North America, California, United States, Palo Alto
Co-Investments: 10

Which angels does New Leaf Venture Partners often collaborate with?

David Baszucki
North America, California, United States, San Mateo
Shared Deals: 1
BD
North America, New York, United States, New York
Shared Deals: 1
Shmuel Cabilly
Asia, HaMerkaz, Israel, Rehovot
Shared Deals: 1
MM
Europe, Ile-de-France, France, Issy-les-moulineaux
Shared Deals: 1
JZ
North America, California, United States, Campbell
Shared Deals: 1
MS
North America, Florida, United States, Miami
Shared Deals: 1

What are some of recent deals done by New Leaf Venture Partners?

Truveris

New York, New York, United States

Truveris is a technology company driving transparency, access and lower costs across the prescription drug ecosystem.

Health CareInformation TechnologySaaSWellness
Series EMay 14, 2024
Amount Raised: $15,000,000
Qlaris Bio

Wellesley, Massachusetts, United States

Qlaris Bio focuses on developing first-in-class therapies for serious and debilitating ophthalmic diseases.

BiotechnologyHealth CareMedical
Series BApr 30, 2024
Amount Raised: $24,000,000
Flosonics

Sudbury, Ontario, Canada

Flosonics is a medical device company that focuses on developing non-invasive sensors to improve the management of critically ill patients.

Health CareMedicalMedical Device
Series CMar 19, 2024
Amount Raised: $20,000,000
Harpoon Therapeutics

South San Francisco, California, United States

Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityOct 23, 2023
Amount Raised: $100,000,000
Arvist

Chicago, Illinois, United States

Arvist improves productivity in warehouses and distribution centers with real-time digital twins without new infrastructure investments

Artificial Intelligence (AI)Computer VisionLogisticsMachine LearningSupply Chain ManagementWarehousing
Pre SeedSep 10, 2023
Amount Raised: $1,000,000
Star Therapeutics

South San Francisco, California, United States

Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.

Health CareMedicalTherapeutics
Series CSep 5, 2023
Amount Raised: $90,000,000
Harpoon Therapeutics

South San Francisco, California, United States

Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityMar 27, 2023
Amount Raised: $25,000,000
Arine

San Francisco, California, United States

Arine optimizes medications and improves human health through data-driven clinical services.

BiotechnologyHealth CareMedicalPharmaceutical
Series BAug 17, 2022
Amount Raised: $29,000,000
Star Therapeutics

South San Francisco, California, United States

Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.

Health CareMedicalTherapeutics
Series UnknownFeb 16, 2022
Amount Raised: $100,000,000
Asimily

Sunnyvale, California, United States

Asimily's IoMT risk remediation platform holistically secures the mission-critical healthcare devices that deliver safe and reliable care.

Cyber SecurityData VisualizationHealth CareHospitalSoftware
Series UnknownNov 2, 2021
Amount Raised: $10,000,000